Cambridge Raman Imaging
Cambridge Raman Imaging (CRI) develops and provides label-free, coherent Raman scattering microscopy for high-speed cell analysis and tissue diagnosis. Their technology integrates ultra-fast fiber-based lasers with Coherent Raman scattering microscopy to enable rapid, high-resolution imaging of tissues. CRI's platform offers a non-invasive approach to histopathology and disease research, aiming to improve diagnostic accuracy and reduce costs for clinicians and researchers. The company was founded in March 2018 and is a spin-out from the University of Cambridge. They have received grant funding from the European Union and investors, and have established a subsidiary in Italy. CRI offers products like CORAL, STRALE, and CHAMP, focusing on advancing biomedical imaging.
Cambridge Raman Imaging
Cambridge Raman Imaging (CRI) develops and provides label-free, coherent Raman scattering microscopy for high-speed cell analysis and tissue diagnosis. Their technology integrates ultra-fast fiber-based lasers with Coherent Raman scattering microscopy to enable rapid, high-resolution imaging of tissues. CRI's platform offers a non-invasive approach to histopathology and disease research, aiming to improve diagnostic accuracy and reduce costs for clinicians and researchers. The company was founded in March 2018 and is a spin-out from the University of Cambridge. They have received grant funding from the European Union and investors, and have established a subsidiary in Italy. CRI offers products like CORAL, STRALE, and CHAMP, focusing on advancing biomedical imaging.